Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis - Jendle, J; Ericsson, Å; Gundgaard, J (Diabetes Ther, 2021)